Literature DB >> 12915586

Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action.

Jinhong Chang1, John M Taylor.   

Abstract

In animal cells, small interfering RNAs (siRNA), when exogenously provided, have been reported to be capable of inhibiting replication of several different viruses. In preliminary studies, siRNA species were designed and tested for their ability to act on the protein expressed in Huh7 cells transfected with DNA-directed mRNA constructs containing hepatitis delta virus (HDV) target sequences. The aim was to achieve siRNA specific for each of the three RNAs of HDV replication: (i) the 1,679-nucleotide circular RNA genome, (ii) its exact complement, the antigenome, and (iii) the less abundant polyadenylated mRNA for the small delta protein. Many of the 16 siRNA tested gave >80% inhibition in this assay. Next, these three classes of siRNA were tested for their ability to act during HDV genome replication. It was found that only siRNA targeted against HDV mRNA sequences could interfere with HDV genome replication. In contrast, siRNA targeted against genomic and antigenomic RNA sequences had no detectable effect on the accumulation of these RNAs. Reconstruction experiments with nonreplicating HDV RNA sequences support the interpretation that neither the potential for intramolecular rod-like RNA folding nor the presence of the delta protein conferred resistance to siRNA. In terms of replicating HDV RNAs, it is considered more likely that the genomic and antigenomic RNAs are resistant because their location within the nucleus makes them inaccessible to siRNA-mediated degradation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915586      PMCID: PMC187427          DOI: 10.1128/jvi.77.17.9728-9731.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Efficient site-specific nonribozyme opening of hepatitis delta virus genomic RNA in infected livers.

Authors:  J Chang; G Moraleda; S Gudima; J Taylor
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

4.  Short interfering RNA confers intracellular antiviral immunity in human cells.

Authors:  Leonid Gitlin; Sveta Karelsky; Raul Andino
Journal:  Nature       Date:  2002-06-26       Impact factor: 49.962

5.  Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications.

Authors:  M Y Kuo; J Goldberg; L Coates; W Mason; J Gerin; J Taylor
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA.

Authors:  Severin Gudima; Jinhong Chang; Gloria Moraleda; Anna Azvolinsky; John Taylor
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

Review 8.  Replication of human hepatitis delta virus: recent developments.

Authors:  John M Taylor
Journal:  Trends Microbiol       Date:  2003-04       Impact factor: 17.079

9.  Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes.

Authors:  J Taylor; W Mason; J Summers; J Goldberg; C Aldrich; L Coates; J Gerin; E Gowans
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

10.  Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.

Authors:  Glen A Coburn; Bryan R Cullen
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  23 in total

1.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 2.  Development of resistance to RNAi in mammalian cells.

Authors:  Zhi-Ming Zheng; Shuang Tang; Mingfang Tao
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

Review 3.  Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Authors:  Florian A Lempp; Yi Ni; Stephan Urban
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

4.  Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.

Authors:  Ji Yuan; Paul K M Cheung; Huifang M Zhang; David Chau; Decheng Yang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs.

Authors:  Susan L Uprichard; Bryan Boyd; Alana Althage; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

6.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

7.  Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection.

Authors:  Sujatha Radhakrishnan; Jennifer Gordon; Luis Del Valle; Jianqi Cui; Kamel Khalili
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes.

Authors:  Prakash K Bhuyan; Katalin Karikò; John Capodici; John Lubinski; Lauren M Hook; Harvey M Friedman; Drew Weissman
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Hepatitis d.

Authors:  Elif S Koytak; Cihan Yurdaydin; Jeffrey S Glenn
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

10.  Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.

Authors:  Kazuo Suzuki; Toshiaki Shijuuku; Toshihiko Fukamachi; John Zaunders; Gilles Guillemin; David Cooper; Anthony Kelleher
Journal:  J RNAi Gene Silencing       Date:  2005-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.